For years, physicians have sought ways to help their patients manage health risks and avert disease before it strikes. Now, a Stanford Medicine pilot program called Humanwide offers a promising new model to do just that, demonstrating how personalized, preventive care that combines biomedicine, digital health and a collaborative team-based approach can lead patients to healthier lives.
“Our vision of precision health is to predict, prevent and cure — precisely,” said Lloyd Minor, MD, dean of the School of Medicine. “Humanwide is that vision realized in a clinical setting. There is so much that each of us can do to be engaged proactively in our health and our well-being.”
Bringing precision health to life
Stanford Medicine has tested a new method of delivering health care that is focused on preventing disease before it takes root.
You race. Kids win.
The annual Summer Scamper will raise money for life-saving research and care at Packard Children’s Hospital.
Concussion advice for young athletes
Stanford pediatric neurosurgeon Gerald Grant, MD, discusses his research aimed at understanding mild traumatic brain injuries in youth and offers pointers on helping teens recover from concussions.
Training the first responders
The Stanford Department of Emergency Medicine is working with nine local fire departments to ensure that crews learn the latest protocols for treating community members during health emergencies.
A FAST track for local teens
A program led by Stanford graduate students is sparking a passion for science careers in local high school students.
New hospital to open for tours
The Sept. 14-15 event will include tours of the new hospital and a street fair featuring booths with demonstrations, food trucks and a variety of health information.
Boosting the health of the community
Stanford’s hospitals provide support that improves the quality of life for many local residents.
For the first time in 18 years … patients with diabetes have a promising option to guard against one of the most severe risks of their condition.
Kenneth Mahaffey, MD, professor of medicine, on his landmark clinical trial of a drug shown to lower the risk of kidney failure by a third in people with Type 2 diabetes and kidney disease.
Newsday, April 15
Now we can see that women with ovarian cancer are dramatically under-tested.
Allison Kurian, MD, associate professor of medicine and of health research and policy, on her study showing the importance of genetic testing for women with ovarian and breast cancer.
Healthline, April 18
We’re learning about biology in a way I think it’s reassuring to know that when you come back things will largely be back to the same.
Michael Snyder, MD, professor and chair of genetics, on the final results of the NASA “twin study,” for which he was a co-principal investigator, showing how Scott Kelly changed after a year in space.
Gizmodo, April 11